Latest Insider Transactions at Nektar Therapeutics (NKTR)
This section provides a real-time view of insider transactions for Nektar Therapeutics (NKTR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEKTAR THERAPEUTICS to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEKTAR THERAPEUTICS's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
10,279
-3.61%
|
$164,464
$16.02 P/Share
|
|
Sep 09
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
10,279
+3.49%
|
$133,627
$13.8 P/Share
|
|
Sep 08
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
8,000
-2.83%
|
$128,000
$16.0 P/Share
|
|
Sep 08
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.76%
|
$104,000
$13.8 P/Share
|
|
Aug 31
2021
|
R Scott Greer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+14.26%
|
$540,000
$12.7 P/Share
|
|
Aug 24
2021
|
Robert Chess |
BUY
Bona fide gift
|
Indirect |
6,300
+50.0%
|
-
|
|
Aug 24
2021
|
Robert Chess |
SELL
Bona fide gift
|
Direct |
6,300
-2.25%
|
-
|
|
Aug 17
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
3,000
-1.23%
|
$39,000
$13.56 P/Share
|
|
Aug 16
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
7,867
-3.13%
|
$102,271
$13.83 P/Share
|
|
Aug 16
2021
|
John Northcott SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,192
-2.99%
|
$80,496
$13.83 P/Share
|
|
Aug 16
2021
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,339
-8.82%
|
$173,407
$13.83 P/Share
|
|
Aug 16
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
11,515
-2.64%
|
$149,695
$13.83 P/Share
|
|
Aug 16
2021
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,910
-2.55%
|
$24,830
$13.83 P/Share
|
|
Aug 16
2021
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
7,662
-3.48%
|
$99,606
$13.83 P/Share
|
|
Jul 22
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
91
-0.03%
|
$1,456
$16.8 P/Share
|
|
Jul 22
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
91
+0.03%
|
$1,183
$13.8 P/Share
|
|
Jul 21
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
3,524
-1.24%
|
$56,384
$16.81 P/Share
|
|
Jul 21
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
3,524
+1.23%
|
$45,812
$13.8 P/Share
|
|
Jul 20
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
2,106
-0.75%
|
$33,696
$16.8 P/Share
|
|
Jul 20
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
2,106
+0.74%
|
$27,378
$13.8 P/Share
|
|
May 17
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
7,898
-3.05%
|
$142,164
$18.3 P/Share
|
|
May 17
2021
|
John Northcott SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,085
-2.85%
|
$109,530
$18.3 P/Share
|
|
May 17
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
11,560
-2.59%
|
$208,080
$18.3 P/Share
|
|
May 17
2021
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,391
-8.14%
|
$241,038
$18.3 P/Share
|
|
May 17
2021
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,917
-2.5%
|
$34,506
$18.3 P/Share
|
|
May 17
2021
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
31,111
-11.69%
|
$559,998
$18.3 P/Share
|
|
May 12
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
8,000
-2.77%
|
$152,000
$19.34 P/Share
|
|
May 12
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.7%
|
$104,000
$13.8 P/Share
|
|
Apr 14
2021
|
Robert Chess |
SELL
Open market or private sale
|
Direct |
8,000
-2.77%
|
$144,000
$18.98 P/Share
|
|
Apr 14
2021
|
Robert Chess |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+2.7%
|
$104,000
$13.8 P/Share
|
|
Feb 16
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
7,977
-2.99%
|
$175,494
$22.37 P/Share
|
|
Feb 16
2021
|
John Northcott SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,358
-6.72%
|
$337,876
$22.37 P/Share
|
|
Feb 16
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
11,495
-2.51%
|
$252,890
$22.37 P/Share
|
|
Feb 16
2021
|
Jillian B. Thomsen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,705
-6.64%
|
$257,510
$22.37 P/Share
|
|
Feb 16
2021
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,173
-2.75%
|
$47,806
$22.37 P/Share
|
|
Feb 16
2021
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
24,141
-8.32%
|
$531,102
$22.37 P/Share
|
|
Feb 04
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-15.77%
|
$950,000
$19.81 P/Share
|
|
Feb 04
2021
|
Gil M Labrucherie SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.63%
|
$400,000
$8.8 P/Share
|
|
Feb 04
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
150,000
-13.17%
|
$3,000,000
$20.34 P/Share
|
|
Feb 04
2021
|
Howard W Robin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+19.77%
|
$1,200,000
$8.8 P/Share
|
|
Feb 03
2021
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,344
-6.34%
|
$101,536
$19.45 P/Share
|
|
Feb 03
2021
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
5,344
-5.97%
|
$42,752
$8.8 P/Share
|
|
Feb 03
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-15.77%
|
$950,000
$19.61 P/Share
|
|
Feb 03
2021
|
Gil M Labrucherie SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.6%
|
$400,000
$8.8 P/Share
|
|
Feb 03
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
150,000
-24.64%
|
$2,850,000
$19.72 P/Share
|
|
Feb 03
2021
|
Howard W Robin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+11.65%
|
$1,200,000
$8.8 P/Share
|
|
Feb 02
2021
|
Gil M Labrucherie SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-5.4%
|
$1,000,000
$20.86 P/Share
|
|
Feb 02
2021
|
Gil M Labrucherie SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.63%
|
$400,000
$8.8 P/Share
|
|
Feb 02
2021
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
150,000
-8.39%
|
$3,000,000
$20.71 P/Share
|
|
Feb 02
2021
|
Howard W Robin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+19.77%
|
$1,200,000
$8.8 P/Share
|